The US has raised fresh concerns about India’s high customs duties on IP-intensive goods and a proposed mandatory blanket license for AI developers using copyrighted works. India is still on the US “Priority Watch List” over weak IP protection, with fears including trade secret disclosure and patent revocations, especially affecting the pharmaceutical sector.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
